Next Article in Journal
Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
Previous Article in Journal
Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
Previous Article in Special Issue
Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac® in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa
 
 
Review

Article Versions Notes

Vaccines 2022, 10(5), 714; https://doi.org/10.3390/vaccines10050714
Action Date Notes Link
article pdf uploaded. 1 May 2022 00:07 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/714/pdf-vor
article pdf uploaded. 1 May 2022 08:23 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/714/pdf-vor
article pdf uploaded. 4 May 2022 09:46 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/714/pdf-vor
article xml file uploaded 9 May 2022 08:33 CEST Original file -
article xml uploaded. 9 May 2022 08:33 CEST Update https://www.mdpi.com/2076-393X/10/5/714/xml
article pdf uploaded. 9 May 2022 08:33 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/714/pdf
article html file updated 9 May 2022 08:34 CEST Original file -
article html file updated 2 August 2022 21:52 CEST Update https://www.mdpi.com/2076-393X/10/5/714/html
Back to TopTop